0001863564-22-000002.txt : 20220520
0001863564-22-000002.hdr.sgml : 20220520
20220520143519
ACCESSION NUMBER: 0001863564-22-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20220520
DATE AS OF CHANGE: 20220520
EFFECTIVENESS DATE: 20220520
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Ventures Fund I, L.P.
CENTRAL INDEX KEY: 0001863564
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-400415
FILM NUMBER: 22947012
BUSINESS ADDRESS:
STREET 1: 351 NEWBURY STREET, 2ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02115
BUSINESS PHONE: 970-759-6000
MAIL ADDRESS:
STREET 1: 351 NEWBURY STREET, 2ND FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02115
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001863564
Cure Ventures Fund I, L.P.
351 Newbury Street
2nd Floor
Boston
MA
MASSACHUSETTS
02115
970-759-6000
DELAWARE
None
None
Limited Partnership
true
2021
N/A
Cure Ventures Fund I GP, LLC
351 Newbury Street
2nd Floor
Boston
MA
MASSACHUSETTS
02115
Executive Officer
General Partner of the Issuer (the "General Partner")
Dave
Fallace
351 Newbury Street
2nd Floor
Boston
MA
MASSACHUSETTS
02115
Executive Officer
Managing Member of the General Partner
Richard
J.
Lim
351 Newbury Street
2nd Floor
Boston
MA
MASSACHUSETTS
02115
Executive Officer
Managing Member of the General Partner
Louis
Tartaglia
351 Newbury Street
2nd Floor
Boston
MA
MASSACHUSETTS
02115
Executive Officer
Managing Member of the General Partner
Pooled Investment Fund
Venture Capital Fund
false
Not Applicable
- 06b
- 3C
- 3C.7
true
0001863564-21-000002
2021-05-25
false
true
false
0
400000000
207868020
192131980
Total amounts include the amount of capital committed by the General Partner of the Issuer.
false
25
0
0
0
An affiliate of the General Partner will receive a fee for management services. The fee will generally equal a percentage of commitments as specified in the Issuer's partnership agreement.
false
Cure Ventures Fund I, L.P.
/s/ Dave Fallace
Dave Fallace
Managing Member of the General Partner
2022-05-20